Evidence map›Paper›PMID 24042216›Full record

ReviewExperimental brain research2013

The serotonin 5-HT7 receptors: two decades of research.

Evelien Gellynck, Karen Heyninck, Kjetil W Andressen, Guy Haegeman, Finn Olav Levy, Peter Vanhoenacker, Kathleen Van Craenenbroeck

Abstract readReview
PubMed Publisher
In one paragraph

Review in Experimental brain research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. The Importance of Stereochemistry in 5-HTACS chemical neuroscience · 2024
    Article
  6. Article
  7. Novel 5-HTAmerican journal of physiology. Gastrointestinal and liver physiology · 2024
    Article
  8. The Formation and Function of the VTA Dopamine System.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Development of a 5-HTNaunyn-Schmiedeberg's archives of pharmacology · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Central nervous system effects of 5-HTMolecular medicine (Cambridge, Mass.) · 2022
    Review
  18. Review
  19. Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).Naunyn-Schmiedeberg's archives of pharmacology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Evelien GellynckLaboratory for Eukaryotic Gene Expression and Signal Transduction (LEGEST), Ghent University, Proeftuinstraat 86, 9000, Ghent, Belgium.
Karen Heyninck
Kjetil W Andressen
Guy Haegeman
Finn Olav Levy
Peter Vanhoenacker
Kathleen Van Craenenbroeck
Ghent University · BEOslo University Hospital · NOGhent University Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Like most neurotransmitters, serotonin possesses a simple structure. However, the pharmacological consequences are more complex and diverse. Serotonin is involved in numerous functions in the human body including the control of appetite, sleep, memory and learning, temperature regulation, mood, behavior, cardiovascular function, muscle contraction, endocrine regulation, and depression. Low levels of serotonin may be associated with several disorders, namely increase in aggressive and angry behaviors, clinical depression, Parkinson's disease, obsessive-compulsive disorder, eating disorders, migraine, irritable bowel syndrome, tinnitus, and bipolar disease. These effects are mediated via different serotonin (5-HT) receptors. In this review, we will focus on the last discovered member of this serotonin receptor family, the 5-HT7 receptor. This receptor belongs to the G protein-coupled receptor superfamily and was cloned two decades ago. Later, different splice variants were described but no major functional differences have been described so far. All 5-HT7 receptor variants are coupled to Gαs proteins and stimulate cAMP formation. Recently, several interacting proteins have been reported, which can influence receptor signaling and trafficking.

Indexed as

AnimalsCyclic AMPHumansMutationReceptors, SerotoninSerotoninSignal TransductionCyclic AMPReceptors, SerotoninSerotoninserotonin 5 receptorserotonin 7 receptor

Identifiers

PMID24042216
OpenAlexW2127897921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.